Axillary lymph node metastases detection with nuclear medicine approaches in patients with newly diagnosed breast cancer: Can Positron Emission Tomography (PET) with 18F-FDG be considered as the best method?

International Journal of Oncology

Volumn 8, Issue 4, 1996, Pages 693-699

  Bombardieri, Emilio ^a   Crippa, Flavio ^a   Maffioli, Lorenzo ^a   Chiti, Arturo ^a   Castellani, Maria Rita ^a   Greco, Marco ^a   Agresti, Roberto ^a   Bogni, Anna ^a   Chiesa, Carlo ^a   De Sanctis, Vinicio ^a   Massaron, Simonetta ^a   Pascali, Claudio ^a  

^a NATIONAL CANCER INSTITUTE   (Italy)

Author keywords

111In Pentetreotide; 18F Fluorodeoxyglucose; 99mTc Sesta MIBI; Breast cancer; Positron emission tomography (PET); Single photon emission tomography (SPET)

Indexed keywords

FLUORINE 18; FLUORODEOXYGLUCOSE; INDIUM 111; METHOXY ISOBUTYL ISONITRILE TECHNETIUM TC 99M; PENTETREOTIDE; TECHNETIUM 99M;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; LYMPH NODE METASTASIS; PHOTON EMISSION TOMOGRAPHY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCINTIGRAPHY;

EID: 9244246300     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. La Vecchia C, Lucchini F, Negri E, Boyle P, Maisonneuve P, Levi F: Trends of cancer mortality in Europe, 1955-1989: III, breast and genital sites. Eur J Cancer 28A: 927-998, 1992.
2. Harris JR, Canellos GP, Hellman S, Fisher B: Cancer of the breast. In: Cancer Principles and Practice of Oncology. VT De Vita Jr, S Hellman, SA Rosenberg (eds.), Philadelphia, JB Lippincott Co. pp1119-1127, 1985.
3. Bonadonna G, Valagussa P, Rossi A, Tancini G, Brambilla C, Zambetti M, Veronesi U: Ten years' experience with CMF-based adjuvant chemotherapy in resectable breast cancer. Breast Cancer Res Treat 5: 95-115, 1986.
4. Tattersall MHN: Breast cancer - fiction, facts and fashion. Med J Aust 147: 318-319, 1987.
5. Bonadonna G: Neoplasie della mammella. In: Manuale di Oncologia Medica. Bonadonna G, Robustelli Della Cuna G (eds.) Milano, Massen, 3rd edit, pp419-446, 1987.
6. Lamki LM, Buzdar AU, Singletary SE, Rosenblum MG, Bhadkamar V, Esparza L, Podoloff DA, Zukiwski A, Hortobagyi GN, Murray J: Indium-111-labeled B72.3 monoclonal antibody in the detection and staging of breast cancer: a phase I study. J Nucl Med 32: 1326-1332, 1991.
7. Mandeville R, Pateisku N, Philipp K, Kubista E, Dumas F, Gronix B: Immunolymphoscintigraphy of axillary lymph node metastases in breast cancer patients using monoclonal antibodies: first clinical findings. Anticancer Res 6: 1257-1264, 1986.
8. Taylor JL, Taylor DN, Lowry C, Keeling AA, Bradwell AR, McIntosh A, Rhodes A: Radioimmunoscintigraphy of metastatic breast carcinoma. Eur J Surg Oncol 18: 57-63, 1992.
9. Crippa F, Agresti R, Bombardieri E, Seregni E, Chiti A, Greco M, Andreola S, Buraggi GL, Veronesi U: Preliminary results of pre-operative axillary radioimmunoscintigraphy with In-111 B72.3 in breast cancer. Int J Oncol 6: 791-795, 1995.
10. 99mTc-MIBI: a comparative study with mammography and ultrasonography. J Nucl Med Commun 15: 604-612, 1994.
11. Van Eijck CHJ, Krenning EP, Bootsma A, Oei HY, Van Pel R, Lindemans J, Jeekel J, Reubi JC, Lamberts SWJ: Somatostatin-receptor scintigraphy in primary breast cancer. Lancet 343: 640-643, 1994.
12. Wahl RL, Cody RL, Hutchins GD, Mudgett EE: Primary and metastatic breast carcinoma: initial clinical evaluation with PET with the radiolabelled glucose analogue 2-(F-18)-fluoro-2-deoxy-D-glucose. Radiology 179: 765-770, 1991.
13. Krenning EP, Bakker WH, Kooij PPM, Breeman WAP, Oei HY, De Jong M, Reubi JC, Visser TJ, Bruns C, Kwekkeboom DJ, Reijs AEM, Van Hagen PM, Koper JW, Lamberts SWJ: Somatostatin receptor scintigraphy with Indium-111-DTPA-D-Phe-1-Octreotide in man: metabolism, dosimetry and comparison with Iodine-123-Tyr-3-Octreotide. J Nucl Med 33: 652-658, 1992.
14. Piwnica-Worms D, Holman BL: Editorial: non cardiac applications of hexakis-(alkylisonitrile) technetium-99m complexes. J Nucl Med 31: 1166-1167, 1990.
15. McBiles M, Lambert AT, Cote MG, Yong Kim S: Sestamibi parathyroid imaging. Semin Nucl Med 25: 221-234, 1995.
16. Caner B, Kitapçl M, Unlu M, Erbengt G, Calikoglu T, Gogus T, Bekdik C: Technetium-99m-MIBI uptake in benign and malignant bone lesions: a comparative study with technetium-99m-MDP. J Nucl Med 33: 319-324, 1992.
17. Khalkhali I, Mena I, Jouanne E: Prone scintimammography in patients with suspicions of carcinoma of the breast. J Am Coll Surg 178: 491-497, 1994.
18. Khalkhali I, Cutrone J, Mena I, Diggles L, Venegas R, Vargas H: Clinical and pathological follow-up of 100 patients with breast lesions studied with scintimammography (SMM). J Nucl Med 35: 22P, 1994.
19. Waxman A, Nagaraj N, Ashok G, Khan S, Yodegar J, Memsic L, Silberman A, Jochelson M, Katz R, Phillips E: Sensitivity and specificity of Tc-99m methoxy isobutyl isonitrile (MIBI) in the evaluation of primary carcinoma of the breast: comparison of palpable and non-palpable lesions with mammography. J Nucl Med 35: 22P, 1994.
20. Nathan MA, Seabold JE, Barloon T, Quesenberry J, Bushnell DL, Robinson RA, Young DC, Kirchner PT: Planar vs SPECT Tc-99m MIBI evaluation of suspicious breast lesions on mammography: histologic correlation. J Nucl Med 35: 229P, 1994.
21. Nagarai N, Waxman A, Ashok G, Khan S, Memsic L, Yadegar J, Phillis E: Comparison of SPECT and planar Tc-99m Sesta MIBI (MIBI) imaging in patients with carcinoma of the breast. J Nucl Med 35: 229P, 1994.
22. Chiti A, Maffioli L, Castellani MR, Gasparini M, Capri G, Bombardieri E: Case report: technetium-99m-hexakis-2-methoxyisobutyl-isonitrile imaging of breast cancer and myocardial infarction in the same patient. Tumori 80: 380-481, 1994.
23. Hamacher K, Coenen HH, Stocklin G: Efficient stereo-specific synthesis of no-carrier-added-2[18F]fluro-2-deoxy-D-glucose using aminoplyether supported nucleohilic substitution. J Nucl Med 27: 235-238, 1986.
24. Kalofonos HP, Sackier JM, Hatzistylianou M, Pervez S, Taylor-Papadimitriou J, Waxman JH, Lavender JP, Wood C, Epenetos AA: Kinetics, quantitative analysis and radioimmunolocalization using indium-111-HMFG1 monoclonal antibody in patients with breast cancer. Br J Cancer 59: 939-942, 1989.
25. Lind P, Smola MG, Lechner P, Ratschek M, Klima G, Koltringer P, Steindorfer P, Eber O: The immunoscintigraphic use of Tc-99m-labelled monoclonal antibodies (BW 431/26) in patients with suspected primary, recurrent and metastatic breast cancer. Int J Cancer 47: 865-869, 1991.
26. Athanassiou A, Pectasides D, Pateniotis K, et al: Immunoscintigraphy with 1-131 labeled HMFG2 and HMFG1 (Fab')2 in the pre-operative detection of clinical and subclinical lymph node metastases in breast cancer patients. Int J Cancer 3 (Suppl): 89-95, 1988.
27. 99mTc-Sesta MIBI in oncology. Tumori (in press).
28. Backus M, Piwnica-Worms D, Hockett D: Microprobe analisys of Tc-MIBI in heart cells: calculation of mitochondrial membrane potential. Am J Phys 265: 178-187, 1993.
29. Piwnica-Worms D, Kronauge JF, Delmon L, Holman BL, Marsh JD: Effect of metabolic inhibition on technetium-99m-MIBI kinetics in cultured chick myocardial cells. J Nucl Med 31: 464-472, 1990.
30. Spieth M, Vasinrapee P, Evans T, Wong D, Wade W, Disher A: SPECT scintimammography for lymphadenopathy: preliminary clinical findings. J Nucl Med 36: 52P, 1995.
31. Taifeller R, Robidoux A, Lambert R, Turpin S, Laperriere J: 99m-Tc-SestaMIBI prone scintimammography in detection of primary breast cancer and axillary lymph node involvement. J Nucl Med 36: 52P, 1995.
32. Wackers FJ, Berman DS, Maddahi J, Watson DD, Beller GA, Strauss HW, Boucher CA, Picard M, Holman BL, Fridrich R, Inglese E, Delaloye B, Bischof-Delaloye A, Camin L, McKusick K: Technetium-99m hexakis 2-methoxyisobutyl isonitrile: human biodistribution, dosimetry, safety, and preliminary comparison to thallium-210 for myocardial perfusion imaging. J Nucl Med 30: 301-311, 1989.
33. Savi AR, Gerundini P, Zoli P, Maffioli L, Compierchio A, Colombo F, Matarrese M, Deutsch E: Biodistribution of Tc-99m methoxy-isobutyl-isonitrile (MIBI) in humans. Eur J Nucl Med 15: 597-600, 1989.
34. Jones SC, Alavi A, Christman D, Montanez I, Wolf AP, Reivich M: The radiation dosimetry of 2-(F-18) fluoro 2-deoxy-D-glucose. J Nucl Med 23: 613-617, 1982.
35. Mejia AA, Nakamura T, Mosatoshi I, Hatarawa J, Masaki M, Watanuki S: Estimation of absorbed doses in humans due to intravenous administration of fluorine-18-fluorodeoxyglucose in PET studies. J Nucl Med 32: 699-706, 1991.